CD19 and immunoglobulin G4-related sclerosing disease: Our previous studies revealed that, compared with healthy control subjects and patients with primary Sjögren’s syndrome, patients with IgG4-RD expressed an increased circulating population of CD19+CD24−CD38hi cells that appeared to be circulating plasmablasts/plasma cells and correlated positively with serum IgG4 levels [17].